1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Drugs and Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Age Related Macular Degeneration
1.4.3 Diabetic Retinopathy
1.4.4 Ocular Inflammatory Disease (Uveitis)
1.4.5 Macular Hole
1.5 Market by Application
1.5.1 Global Retinal Drugs and Biologics Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Retinal Drugs and Biologics Market
1.8.1 Global Retinal Drugs and Biologics Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Retinal Drugs and Biologics Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Retinal Drugs and Biologics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Retinal Drugs and Biologics Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Retinal Drugs and Biologics Sales Volume Market Share by Region (2015-2020)
3.2 Global Retinal Drugs and Biologics Sales Revenue Market Share by Region (2015-2020)
3.3 North America Retinal Drugs and Biologics Sales Volume
3.3.1 North America Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.3.2 North America Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Retinal Drugs and Biologics Sales Volume
3.4.1 East Asia Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Retinal Drugs and Biologics Sales Volume (2015-2020)
3.5.1 Europe Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Retinal Drugs and Biologics Sales Volume (2015-2020)
3.6.1 South Asia Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Retinal Drugs and Biologics Sales Volume (2015-2020)
3.7.1 Southeast Asia Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Retinal Drugs and Biologics Sales Volume (2015-2020)
3.8.1 Middle East Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Retinal Drugs and Biologics Sales Volume (2015-2020)
3.9.1 Africa Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Retinal Drugs and Biologics Sales Volume (2015-2020)
3.10.1 Oceania Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Retinal Drugs and Biologics Sales Volume (2015-2020)
3.11.1 South America Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.11.2 South America Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Retinal Drugs and Biologics Sales Volume (2015-2020)
3.12.1 Rest of the World Retinal Drugs and Biologics Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Retinal Drugs and Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Retinal Drugs and Biologics Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Retinal Drugs and Biologics Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Retinal Drugs and Biologics Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Retinal Drugs and Biologics Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Retinal Drugs and Biologics Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Retinal Drugs and Biologics Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Retinal Drugs and Biologics Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Retinal Drugs and Biologics Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Retinal Drugs and Biologics Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Retinal Drugs and Biologics Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Retinal Drugs and Biologics Sales Volume Market Share by Type (2015-2020)
14.2 Global Retinal Drugs and Biologics Sales Revenue Market Share by Type (2015-2020)
14.3 Global Retinal Drugs and Biologics Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Retinal Drugs and Biologics Consumption Volume by Application (2015-2020)
15.2 Global Retinal Drugs and Biologics Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Retinal Drugs and Biologics Business
16.1 ALLERGAN
16.1.1 ALLERGAN Company Profile
16.1.2 ALLERGAN Retinal Drugs and Biologics Product Specification
16.1.3 ALLERGAN Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Genzyme
16.2.1 Genzyme Company Profile
16.2.2 Genzyme Retinal Drugs and Biologics Product Specification
16.2.3 Genzyme Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Janssen Biotech
16.3.1 Janssen Biotech Company Profile
16.3.2 Janssen Biotech Retinal Drugs and Biologics Product Specification
16.3.3 Janssen Biotech Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 AbbVie
16.4.1 AbbVie Company Profile
16.4.2 AbbVie Retinal Drugs and Biologics Product Specification
16.4.3 AbbVie Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Bristol-Myers Squibb
16.5.1 Bristol-Myers Squibb Company Profile
16.5.2 Bristol-Myers Squibb Retinal Drugs and Biologics Product Specification
16.5.3 Bristol-Myers Squibb Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Alimera Sciences
16.6.1 Alimera Sciences Company Profile
16.6.2 Alimera Sciences Retinal Drugs and Biologics Product Specification
16.6.3 Alimera Sciences Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 OCULAR THERAPEUTIX
16.7.1 OCULAR THERAPEUTIX Company Profile
16.7.2 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Specification
16.7.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Roche
16.8.1 Roche Company Profile
16.8.2 Roche Retinal Drugs and Biologics Product Specification
16.8.3 Roche Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Swedish Orphan Biovitrum
16.9.1 Swedish Orphan Biovitrum Company Profile
16.9.2 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Specification
16.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Genentech
16.10.1 Genentech Company Profile
16.10.2 Genentech Retinal Drugs and Biologics Product Specification
16.10.3 Genentech Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Bausch & Lomb
16.11.1 Bausch & Lomb Company Profile
16.11.2 Bausch & Lomb Retinal Drugs and Biologics Product Specification
16.11.3 Bausch & Lomb Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 UCBCares
16.12.1 UCBCares Company Profile
16.12.2 UCBCares Retinal Drugs and Biologics Product Specification
16.12.3 UCBCares Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Retinal Drugs and Biologics Manufacturing Cost Analysis
17.1 Retinal Drugs and Biologics Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Retinal Drugs and Biologics
17.4 Retinal Drugs and Biologics Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Retinal Drugs and Biologics Distributors List
18.3 Retinal Drugs and Biologics Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Retinal Drugs and Biologics (2021-2026)
20.2 Global Forecasted Revenue of Retinal Drugs and Biologics (2021-2026)
20.3 Global Forecasted Price of Retinal Drugs and Biologics (2015-2026)
20.4 Global Forecasted Production of Retinal Drugs and Biologics by Region (2021-2026)
20.4.1 North America Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.3 Europe Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.7 Africa Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.9 South America Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Retinal Drugs and Biologics Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Retinal Drugs and Biologics by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Retinal Drugs and Biologics by Country
21.2 East Asia Market Forecasted Consumption of Retinal Drugs and Biologics by Country
21.3 Europe Market Forecasted Consumption of Retinal Drugs and Biologics by Countriy
21.4 South Asia Forecasted Consumption of Retinal Drugs and Biologics by Country
21.5 Southeast Asia Forecasted Consumption of Retinal Drugs and Biologics by Country
21.6 Middle East Forecasted Consumption of Retinal Drugs and Biologics by Country
21.7 Africa Forecasted Consumption of Retinal Drugs and Biologics by Country
21.8 Oceania Forecasted Consumption of Retinal Drugs and Biologics by Country
21.9 South America Forecasted Consumption of Retinal Drugs and Biologics by Country
21.10 Rest of the world Forecasted Consumption of Retinal Drugs and Biologics by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer